Abbott Laboratories (NYSE:ABT) Stock Position Trimmed by Bellevue Group AG

Bellevue Group AG lessened its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 1.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,535,656 shares of the healthcare product maker’s stock after selling 25,312 shares during the quarter. Abbott Laboratories accounts […]

Related Keywords

Canada , Lisad Earnhardt , Roberte Funck , Raymond James , Citigroup , Bellevue Group , Wealth Management Group , Securities Exchange Commission , Rise Advisors , Signature Resources Capital Management , Goldman Sachs Group , Abbott Laboratories , Stuart Chaussee Associates Inc , Barclays , Royal Bank , Free Report , Resources Capital Management , Laboratories Stock Down , Get Free Report , Exchange Commission , Established Pharmaceutical Products , Diagnostic Products , Nutritional Products , Abbott Laboratories Daily ,